ENDOGEN ApS: Financial statements 2014
CVR: 29813337
Source: annual report 2014, Danish Business Authority
27/10/2013 – 26/10/2014
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 18,625 and a net result of DKK -36,822 compared with DKK -14,190 the year before. The profit margin was -197.7%. Equity in the 2014 report amounted to DKK 70,093. The solvency ratio was 100%.
- Revenue
- DKK 18,625
- Gross Profit
- DKK -36,293
- Profit/Loss
- DKK -36,822
- Equity
- DKK 70,093
- Total Assets
- DKK 70,093
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 19 t. | -36 t. | -37 t. | 70 t. | - |
| 2013 | 0 | -14 t. | -14 t. | 107 t. | - |
| 2012 | 0 | -990 | -1 t. | 121 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ENDOGEN ApS has published its annual report for 2013. Revenue came to DKK 0, and the net result was DKK -14,190.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity in the 2025 report amounted to DKK -82,428.